Loading...
Skip to main content

   Corporate News

SYNLAB and Microba Advance Partnership with Latest-Generation Microbiome Testing

SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences have entered into a new three-year agreement to advance their partnership in microbiome diagnostics across selected markets in Europe and Latin America.

Building on a partnership established in 2020, the new agreement marks the transition from Microba’s legacy Insight test to its latest-generation clinical-grade Microbiome Explorer platform. The platform will be integrated into SYNLAB’s diagnostic offering and digital systems, enabling SYNLAB to make the upgraded microbiome testing solution available to healthcare professionals and patients across its network.

The next phase of the partnership combines Microba’s leading expertise in microbiome analysis with SYNLAB’s medical excellence, diagnostic capabilities and established healthcare network.

Through this upgrade, Microba and SYNLAB aim to support access to advanced microbiome insights and further develop their microbiome diagnostics offering across Europe and Latin America.

Keywords: